-
Electronic (PDF)
-
Site License
-
Enterprisewide
Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2012
GlobalData, July 2012, Pages: 99
Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2012
Summary
Our clinical trial report, “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2012" provides data on the Idiopathic (Essential) Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Idiopathic (Essential) Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Idiopathic (Essential) Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Idiopathic (Essential) Hypertension Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Idiopathic (Essential) Hypertension, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
List of Tables
List of Figures
Introduction
Idiopathic (Essential) Hypertension
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Idiopathic (Essential) Hypertension
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Idiopathic (Essential) Hypertension Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Daiichi Sankyo Company, Limited
Clinical Trial Overview of Daiichi Sankyo Company, Limited
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
Novartis AG
Clinical Trial Overview of Novartis AG
Dainippon Sumitomo Pharma Co., Ltd.
Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd.
Shionogi & Co., Ltd.
Clinical Trial Overview of Shionogi & Co., Ltd.
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Ajinomoto Co., Inc.
Clinical Trial Overview of Ajinomoto Co., Inc.
Forest Laboratories, Inc.
Clinical Trial Overview of Forest Laboratories, Inc.
Recordati S.p.A.
Clinical Trial Overview of Recordati S.p.A.
A. Menarini Industrie Farmaceutiche Riunite Srl
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl
Takeda Global Research and Development Center, Inc
Clinical Trial Overview of Takeda Global Research and Development Center, Inc
Daiichi Sankyo, Inc.
Clinical Trial Overview of Daiichi Sankyo, Inc.
Institut fur Pharmakologie und Praventive Medizin GmbH
Clinical Trial Overview of Institut fur Pharmakologie und Praventive Medizin GmbH
Sigma-Tau S.p.A.
Clinical Trial Overview of Sigma-Tau S.p.A.
Shionogi Inc.
Clinical Trial Overview of Shionogi Inc.
Jeil Pharmaceutical Co., Ltd.
Clinical Trial Overview of Jeil Pharmaceutical Co., Ltd.
Hanmi Holdings Co., Ltd.
Clinical Trial Overview of Hanmi Holdings Co., Ltd.
Gedeon Richter Plc
Clinical Trial Overview of Gedeon Richter Plc
Dr. Reddy's Laboratories Limited
Clinical Trial Overview of Dr. Reddy's Laboratories Limited
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Institut de Recherches Internationales Servier
Clinical Trial Overview of Institut de Recherches Internationales Servier
Regional Hospital Holstebro
Clinical Trial Overview of Regional Hospital Holstebro
Addenbrooke's Hospital
Clinical Trial Overview of Addenbrooke's Hospital
Kochi Medical School
Clinical Trial Overview of Kochi Medical School
African Population & Health Research Center
Clinical Trial Overview of African Population & Health Research Center
Elderly Hypertension Conference
Clinical Trial Overview of Elderly Hypertension Conference
Kanazawa University Hospital
Clinical Trial Overview of Kanazawa University Hospital
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Rajiv Gandhi University of Health Sciences
Clinical Trial Overview of Rajiv Gandhi University of Health Sciences
Nippon Medical School Hospital
Clinical Trial Overview of Nippon Medical School Hospital
Sapporo Medical University
Clinical Trial Overview of Sapporo Medical University
Ehime University Graduate School of Medicine
Clinical Trial Overview of Ehime University Graduate School of Medicine
Universidad de Antioquia
Clinical Trial Overview of Universidad de Antioquia
Cardiovascular Institute & Fuwai Hospital
Clinical Trial Overview of Cardiovascular Institute & Fuwai Hospital
University Hospital Virgen de las Nieves
Clinical Trial Overview of University Hospital Virgen de las Nieves
Aarhus University Hospital
Clinical Trial Overview of Aarhus University Hospital
The University of Texas Southwestern Medical Center at Dallas
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas
Third Military Medical University
Clinical Trial Overview of Third Military Medical University
University of Wurzburg
Clinical Trial Overview of University of Wurzburg
University Hospital Freiburg
Clinical Trial Overview of University Hospital Freiburg
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source
List of Tables
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, BRIC Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, G7 Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, E7 Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Dainippon Sumitomo Pharma Co., Ltd., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi & Co., Ltd., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajinomoto Co., Inc., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Recordati S.p.A., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Global Research and Development Center, Inc, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut fur Pharmakologie und Praventive Medizin GmbH, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi Inc., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Jeil Pharmaceutical Co., Ltd., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanmi Holdings Co., Ltd., 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Gedeon Richter Plc, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Regional Hospital Holstebro, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Addenbrooke's Hospital, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Kochi Medical School, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by African Population & Health Research Center, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Elderly Hypertension Conference, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa University Hospital, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Rajiv Gandhi University of Health Sciences, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Medical School Hospital, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapporo Medical University, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Ehime University Graduate School of Medicine, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidad de Antioquia, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiovascular Institute & Fuwai Hospital, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Virgen de las Nieves, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wurzburg, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012-
List of Figures
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, G7 Countries (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, E7 Countries (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Idiopathic (Essential) Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Idiopathic (Essential) Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
